Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies.
HLA-E
NK
NKG2A
Qa-1b
intratumoral immunotherapy
Journal
EMBO molecular medicine
ISSN: 1757-4684
Titre abrégé: EMBO Mol Med
Pays: England
ID NLM: 101487380
Informations de publication
Date de publication:
08 11 2023
08 11 2023
Historique:
revised:
04
09
2023
received:
04
04
2023
accepted:
07
09
2023
medline:
9
11
2023
pubmed:
2
10
2023
entrez:
2
10
2023
Statut:
ppublish
Résumé
NK-cell reactivity against cancer is conceivably suppressed in the tumor microenvironment by the interaction of the inhibitory receptor NKG2A with the non-classical MHC-I molecules HLA-E in humans or Qa-1
Identifiants
pubmed: 37782273
doi: 10.15252/emmm.202317804
pmc: PMC10630884
doi:
Substances chimiques
Antibodies, Monoclonal
0
Histocompatibility Antigens Class I
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e17804Informations de copyright
© 2023 The Authors. Published under the terms of the CC BY 4.0 license.
Références
EMBO Mol Med. 2023 Nov 8;15(11):e17804
pubmed: 37782273
Cancer Cell. 2019 Dec 9;36(6):613-629.e7
pubmed: 31761658
J Exp Med. 1998 Nov 16;188(10):1841-8
pubmed: 9815261
Cancer Cell. 2022 Jun 13;40(6):569-574
pubmed: 35487216
Cancer Discov. 2019 Aug;9(8):1124-1141
pubmed: 31186238
Nat Med. 2002 Aug;8(8):793-800
pubmed: 12091876
J Transl Med. 2023 Mar 2;21(1):162
pubmed: 36864446
Immunity. 2003 Oct;19(4):561-9
pubmed: 14563320
Nat Rev Clin Oncol. 2021 Feb;18(2):85-100
pubmed: 32934330
Front Immunol. 2020 Feb 11;11:7
pubmed: 32117218
Nat Med. 2018 Aug;24(8):1178-1191
pubmed: 29942093
Cell. 2018 Dec 13;175(7):1731-1743.e13
pubmed: 30503213
Nature. 1998 Feb 19;391(6669):795-9
pubmed: 9486650
Nat Biotechnol. 2023 Sep;41(9):1296-1306
pubmed: 36635380
Oncoimmunology. 2018 May 10;7(8):e1461305
pubmed: 30221057
Cancer Discov. 2014 May;4(5):522-6
pubmed: 24795012
Clin Cancer Res. 2019 Oct 15;25(20):6052-6060
pubmed: 31308062
Trends Immunol. 2022 Nov;43(11):932-946
pubmed: 36306739
BMC Neurol. 2020 Feb 17;20(1):59
pubmed: 32066399
Blood. 2009 Jun 25;113(26):6593-602
pubmed: 19406986
Blood. 2004 Dec 1;104(12):3664-71
pubmed: 15304389
Immunity. 2019 Jan 15;50(1):195-211.e10
pubmed: 30635237
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5199-204
pubmed: 9560253
Eur J Cancer. 2021 Oct 9;158:17-26
pubmed: 34638090
Curr Opin Immunol. 2017 Apr;45:73-81
pubmed: 28236750
Scand J Immunol. 2002 Mar;55(3):221-8
pubmed: 11940227
J Cancer Res Clin Oncol. 2023 Aug;149(9):5705-5715
pubmed: 36547689
J Clin Oncol. 2022 Oct 10;40(29):3383-3393
pubmed: 35452273
N Engl J Med. 2020 Feb 6;382(6):545-553
pubmed: 32023374
J Hematol Oncol. 2022 Nov 8;15(1):164
pubmed: 36348457
Science. 2008 Nov 14;322(5904):1097-100
pubmed: 19008445
Blood. 2016 Mar 3;127(9):1202-5
pubmed: 26738538
Semin Immunol. 2014 Apr;26(2):173-9
pubmed: 24613727
Cancer Res. 2013 Jan 1;73(1):139-49
pubmed: 23149919
Semin Immunol. 2023 Jan;65:101706
pubmed: 36542944
J Immunother Cancer. 2019 Oct 17;7(1):263
pubmed: 31623687
J Exp Med. 1999 Dec 20;190(12):1801-12
pubmed: 10601355
Mol Cancer Res. 2021 Jun;19(6):1076-1084
pubmed: 33674442
J Immunol. 2006 Nov 1;177(9):5759-60
pubmed: 17056497
Science. 2018 Nov 9;362(6415):694-699
pubmed: 30409884
Nat Rev Immunol. 2023 Feb;23(2):90-105
pubmed: 35637393
Methods Mol Biol. 2016;1441:167-74
pubmed: 27177665
Cell Rep Med. 2023 Mar 17;:100978
pubmed: 36933554
Clin Cancer Res. 2020 Nov 1;26(21):5549-5556
pubmed: 32409305
Cancer Sci. 2004 Jan;95(1):98-103
pubmed: 14720334
J Immunol. 2022 Aug 1;209(3):629-640
pubmed: 35840162
Methods Enzymol. 2020;631:257-275
pubmed: 31948551
J Immunol. 2005 Mar 1;174(5):2878-84
pubmed: 15728498
JCI Insight. 2019 Jun 18;5:
pubmed: 31211693
Cancer Sci. 2020 Aug;111(8):3057-3070
pubmed: 32495519
Nat Rev Clin Oncol. 2021 Sep;18(9):558-576
pubmed: 34006998
Cell. 2018 Dec 13;175(7):1744-1755.e15
pubmed: 30503208
Blood. 2005 Apr 15;105(8):3051-7
pubmed: 15632206
J Immunother Cancer. 2020 Mar;8(1):
pubmed: 32217765
J Immunother Cancer. 2020 Apr;8(1):
pubmed: 32253221
J Exp Med. 2012 Sep 24;209(10):1869-82
pubmed: 22927549
J Immunol. 1998 May 15;160(10):4951-60
pubmed: 9590243
J Immunother. 2008 Jun;31(5):458-65
pubmed: 18463539
Mol Immunol. 2022 Apr;144:58-70
pubmed: 35203022
Int Rev Cell Mol Biol. 2022;370:65-122
pubmed: 35798507
Cell. 2018 Feb 22;172(5):1022-1037.e14
pubmed: 29429633
Adv Exp Med Biol. 2017;1036:65-79
pubmed: 29275465